GGrantIndex
Sort

17,828 grants matching crispr

GENETICALLY ENGINEERED T CELLS FOR DIPG

$503,626
Giedre Krenciute · St. Jude Children'S Research Hospital · R01 · FY2025 · NS

GENETICALLY ENGINEERED T CELLS FOR DIPG

$503,626
Giedre Krenciute · St. Jude Children'S Research Hospital · R01 · FY2022 · NS

CRX AND ITS REGULATORY NETWORK IN RETINAL DEGENERATIONS

$503,579
Shiming Chen · Washington University · R01 · FY2021 · EY

CRX AND ITS REGULATORY NETWORK IN RETINAL DEGENERATIONS

$503,579
Shiming Chen · Washington University · R01 · FY2022 · EY

Identifying and understanding drivers of chemoresistance in small cell lung cancer

$503,547
David Macpherson · Fred Hutchinson Cancer Center · R01 · FY2024 · CA

Organization and Function of the Periactive Zone

$503,395
Avital Adah Rodal · Brandeis University · R01 · FY2025 · NS

Project 1 Mouse Models Analysis

$503,335
Edgar G. Engleman · Stanford University · U54 · FY2024 · CA

Identifying metabolic dependencies in Hurthle cell carcinoma of the thyroid-Res 1

$503,309
David Glenn McFadden · Ut Southwestern Medical Center · R01 · FY2024 · CA

Resource Core II: In Vivo Core

$503,215
Victor Steven Van Laar · University Of California Berkeley · U19 · FY2024 · NS

Mechanisms of Control of Lymphocyte Activation and Proliferation by a Critical Signaling Integrator

$503,107
Joel L Pomerantz · Johns Hopkins University · R01 · FY2024 · AI

Statistical Methods and Algorithms for Population Genomic Inference

$503,088
Bruce Rannala · University Of California At Davis · R01 · FY2021 · GM

Deciphering pathways involved in topoisomerase II turnover

$502,965
Junjie Chen · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA

Deciphering pathways involved in topoisomerase II turnover

$502,965
Junjie Chen · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA

PROMINENT - IARC

$502,922
Paul Joseph Brennan · International Agency For Res On Cancer · OT2 · FY2024 · CA

Targeting Systems Vulnerabilities in the Gαq/GNAQ Oncogenic Signaling Circuitry: New Precision Therapies for Uveal Melanoma

$502,859
J. Silvio Gutkind · University Of California, San Diego · R01 · FY2024 · CA

Mutant p53 in Tumorigenesis, Invasion, and Metastasis

$502,841
Francisco Javier Sanchez-Rivera · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · CA

Stress responses in embryonic stem cells

$502,812
Jing Huang · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Pathomechanisms of SCN3A-related neurodevelopmental disorder

$502,753
Ethan M Goldberg · Children'S Hosp Of Philadelphia · R01 · FY2024 · NS

Characterizing TP53 and PPM1D mutations as resistance drivers to radiation therapy in Diffuse Intrinsic Pontine Gliomas

$502,615
Rameen Beroukhim · Broad Institute, Inc. · R01 · FY2017 · CA

Development of Potent Estrogen Receptor Beta Agonists for Treating Glioblastoma

$502,525
Ratna K Vadlamudi · University Of Texas Hlth Science Center · R01 · FY2024 · CA

Liver-directed somatic gene correction rAAV system of regulatable Cas9/sgRNA

$502,500
Wen Xue · Univ Of Massachusetts Med Sch Worcester · P01 · FY2016 · HL

Liver-directed somatic gene correction rAAV system of regulatable Cas9/sgRNA

$502,500
Wen Xue · Univ Of Massachusetts Med Sch Worcester · P01 · FY2020 · HL

Liver-directed somatic gene correction rAAV system of regulatable Cas9/sgRNA

$502,500
Wen Xue · Univ Of Massachusetts Med Sch Worcester · P01 · FY2019 · HL

Mechanisms of enhancer regulation in leukemia

$502,459
Iannis Aifantis · New York University School Of Medicine · R01 · FY2020 · CA

Mechanisms of enhancer regulation in leukemia

$502,459
Iannis Aifantis · New York University School Of Medicine · R01 · FY2021 · CA